A new study examines the occurrence of interval colorectal cancer despite regular colonoscopy and highlights the importance of close follow-up for patients who have a history of advanced adenomas, which are precancerous polyps.
Neuroscientists at MIT have developed a powerful new class of tools to reversibly shut down brain activity using different colors of light
Researchers from the University of Minnesota Medical School discovered that light from an ultraviolet diode (UV LED) reduced "seizure-like" activity in a rat epilepsy model. During the study, UV light released gamma aminobutyric acid (GABA) from the "caged" compound carbonyl amino butanoic acid (BC204).
Sirona (NASDAQ: SIRO), the dental technology leader, today announced the launch of the InEos Blue desktop scanner, an advanced 3D scanner that allows dental technicians to quickly, precisely and easily scan dental models. The InEos Blue is built on Sirona’s innovative Bluecam technology, which utilizes short-wavelength visible blue light to facilitate flexible recording options, resulting in substantially faster scanning and precise 3D digital models.
PixelOptics, Inc. ("Pixel") of Roanoke, Virginia announced today that Pixel and Panasonic Shikoku Electronics Co., Ltd ("Panasonic Shikoku Electronics") of Matsuyama, Japan have been collaborating in the development of PixelOptics' electronic eyeglasses. Pixel, the world's first composite ophthalmic lens company, is developing, and plans to market and sell both static (fixed focus) and electronic dynamic (changeable focus) lenses.
Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacture and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, announced today receipt of CE mark for their OCT (Optical Coherence Tomography) imaging system and catheter. Volcano's OCT product line is expected to complement its existing line of IVUS imaging catheters and pressure guide wires used for coronary imaging and lesion assessment.
Cardiogenesis Corporation (Pink Sheets: CGCP), today announced that it has submitted an IDE (Investigational Device Exemption) to the Food and Drug Administration to initiate a safety and feasibility trial for its PHOENIX System in patients with refractory angina. The PHOENIX handpiece is the first device specifically designed to allow physician-directed tissue stimulation and injections of biologic or pharmacologic agents to pre-determined areas of myocardium.
Bausch & Lomb today announced that it is launching the Crystalens® AO, the first aberration-free accommodating intraocular lens (IOL) with aspheric optics to cataract surgeons worldwide. The announcement follows the recent FDA approval of this newest Bausch & Lomb surgical product. The Crystalens AO, combined with the successful Crystalens HD and the Crystalens Five-0, will further establish Crystalens as the market leader in the premium IOL market.
Forecasts for the global market in systems, providing data for 2008 and estimates for 2009, and projections for the market and compound annual growth rates (CAGRs) from 2009 to 2014 An overview of medical laser applications, including cosmetic, diagnostic, surgical, and therapeutic A breakdown of the market by regions, and by technologies, including gas, dye, metal-vapor, and solid-state lasers.
Stryker Corporation (NYSE: SYK) today announced the closing of its previously announced acquisition of Ascent Healthcare Solutions, the market leader in the reprocessing and remanufacturing of medical devices in the U.S.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.